AptarGroup Hosts Analyst Day in New York City

AptarGroup  hosted an Analyst Day in New York City on Thursday, September 11, 2014, providing analysts with an in-depth look at Aptar’s product offerings, financial results and plans for the future. Senior executives from the company also answered questions from the audience and demonstrated the innovative dispensing solutions provided by Aptar’s Beauty + Home, Food + Beverage and Pharma segments. In addition to the meeting, some attendees of the event also participated in a tour of Aptar Congers facility in New York, which molds and assembles prescription nasal pumps, actuators and sublingual unit dosing devices.

 “Aptar had a good first half of the year with  broad-based sales growth across our diversified business,” explained Steve Hagge, President and CEO, AptarGroup. “Each business segment is reporting first half core sales growth and we are up in each of the eight end markets we serve. We also entered or expanded in several new market categories including liquid concentrated flavoring, infant formula, ophthalmics,  over the counter nasal rhinitis treatments and concentrated cleaners.”

Interested parties can access the Analyst Day presentation slides and listen to the recorded webcast by visiting the Investor Relations page of AptarGroup’s website at www.aptar.com. As previously announced, AptarGroup plans to report its 2014 third quarter results after trading on the New York Stock Exchange has closed on Thursday, October 30, 2014. AptarGroup will hold a conference call on Friday, October 31, 2014, at 8:00 a.m. CDT (9:00 a.m. EDT) to discuss the third quarter results. The conference call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investor Relations page of the AptarGroup website. Replay of the conference call can also be accessed on the Investor Relations page of the website.

Congers2

Photo: Aptar Pharma products on display as part of a tour of the Aptar Congers facility in New York on September 11.